jordan Berlin

Professor

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jordan Berlin is a Professor at Vanderbilt University Medical Center in the United States. His research focuses on the management and treatment of advanced cancers, with a particular emphasis on rectal and colon cancers, as well as neuroendocrine tumors. He has contributed to significant clinical guidelines and has conducted various studies evaluating the safety and efficacy of novel therapies in oncology.

Articles (9)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (6)

Satya Das

Assistant Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

Elizabeth Swisher

Professor

University of Washington

UNITED STATES

View details

Sharon Phillips

Vanderbilt University Medical Center

UNITED STATES

View details

Robert Ramirez

Vanderbilt University Medical Center

UNITED STATES

View details

Rajiv Agarwal

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Nancy Baxter

Professor and Head of School

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

jordan Berlin

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights

Management of Locally Advanced Rectal Cancer: ASCO Guideline

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations

Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient Mortality

Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours – A systematic review and meta-analysis

First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

Collaborators (6)

Satya Das

Elizabeth Swisher

Sharon Phillips

Robert Ramirez

Rajiv Agarwal

Nancy Baxter

Make your next move.